Ignite Creation Date:
2025-12-25 @ 2:33 AM
Ignite Modification Date:
2026-02-28 @ 11:20 AM
Study NCT ID:
NCT02452034
Status:
COMPLETED
Last Update Posted:
2019-07-26
First Post:
2015-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-20
First Submit QC Date:
None
Study First Post Date:
2015-05-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-21
Results First Submit QC Date:
None
Results First Post Date:
2019-07-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-28
Last Update Post Date:
2019-07-26
Last Update Post Date Type:
ACTUAL